Cresset Biomolecular Discovery Limited
04151475
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/03/2025
group
Next accounts due
31/12/2026
Confirmation statement
Last: 30/09/2025
Due 14/10/2026
Industry
Officers
director · Since 19/04/2010
DIRECTOR
BRITISH · UNITED KINGDOM · Age 60
Also on 1 other board
secretary · Since 04/05/2017
director · Since 13/02/2020
DIRECTOR AND COMPANY SECRETARY
BRITISH · UNITED KINGDOM · Age 51
Also on 1 other board
director · Since 14/10/2021
DIRECTOR
BRITISH · UNITED KINGDOM · Age 55
Also on 1 other board
Persons with Significant Control
Sep Vi L.P.
17, Blythswood Square, Glasgow, G2 4AD
Notified 15/09/2022
Former PSCs
Dr Jeremy Gilbert Vinter
Ceased 08/12/2020
CompanyRankvs 1964+ SIC 62012 peers82
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2022
Net Worth
£2.1M
Balance sheet strength
Cash
£2.0M
Cash in the bank
Net Current Assets
£736k
Working capital
Current Assets
£4.6M
Current Liabilities
£3.9M
Fixed Assets
£1.4M
Debtors
£2.6M
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2022 | 1.19 |
Derived from filed accounts. Not audited figures.